Randomised double-blind trial of megestrol acetate vs placebo in treatment-naive advanced hepatocellular carcinoma

BACKGROUND: Hepatocellular carcinoma (HCC) is the third leading cause of cancer deaths worldwide. We tested megestrol acetate (MA) against placebo in the treatment of advanced HCC. METHODS: From 2002 through 2007, this randomised double-blind trial enrolled 204 patients with treatment-naive advanced...

Descripción completa

Detalles Bibliográficos
Autores principales: Chow, P K H, Machin, D, Chen, Y, Zhang, X, Win, K-M, Hoang, H-H, Nguyen, B-D, Jin, M-Y, Lobo, R, Findlay, M, Lim, C-H, Tan, S-B, Gandhi, M, Soo, K-C
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2011
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3185948/
https://www.ncbi.nlm.nih.gov/pubmed/21863030
http://dx.doi.org/10.1038/bjc.2011.333

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3185948/
https://www.ncbi.nlm.nih.gov/pubmed/21863030
http://dx.doi.org/10.1038/bjc.2011.333

Ejemplares similares